BMEZ (BlackRock Health Sciences Trust II) EPS (Basic) : $-0.16 (TTM As of Jun. 2024)

View and export this data going back to 1990. Start your Free Trial

What is BlackRock Health Sciences Trust II EPS (Basic)?

BlackRock Health Sciences Trust II's basic earnings per share (Basic EPS) for the six months ended in Jun. 2024 was $0.28. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.16.

BlackRock Health Sciences Trust II's EPS (Diluted) for the six months ended in Jun. 2024 was $0.28. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.21.

BlackRock Health Sciences Trust II's EPS without NRI for the six months ended in Jun. 2024 was $0.28. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was -0.21.

During the past 12 months, BlackRock Health Sciences Trust II's average EPS without NRIGrowth Rate was -111.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was -60.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, BlackRock Health Sciences Trust II's highest 3-Year average EPS without NRI Growth Rate was -60.30% per year. The lowest was -60.30% per year. And the median was -60.30% per year.

BlackRock Health Sciences Trust II EPS (Basic) Historical Data

The historical data trend for BlackRock Health Sciences Trust II's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BlackRock Health Sciences Trust II EPS (Basic) Chart

BlackRock Health Sciences Trust II Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

11.63

-2.55

-5.97

0.73

BlackRock Health Sciences Trust II Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EPS (Basic)	Get a 7-Day Free Trial				-6.69	0.72	1.17	-0.44	0.28

BlackRock Health Sciences Trust II EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

BlackRock Health Sciences Trust II's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(69.859	-	0)	/	95.697
	=	0.73

BlackRock Health Sciences Trust II's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(29.745	-	0)	/	106.232
	=	0.28

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.16

BlackRock Health Sciences Trust II (NYSE:BMEZ) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

BlackRock Health Sciences Trust II EPS (Basic) Related Terms

Thank you for viewing the detailed overview of BlackRock Health Sciences Trust II's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

BlackRock Health Sciences Trust II Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BlackRock Health Sciences Trust II (NYSE:BMEZ) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Bellevue Parkway, Wilmington, DE, USA, 19809

Website

https://www.blackrock.com

BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.

Executives

Saba Capital Management, L.p.	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Christopher Accettella	other: Portfolio Manager	100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Kyle Mcclements	other: Portfolio Manager	100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Boaz Weinstein	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Arthur Philip Steinmetz	director	50 HUDSON YARDS, NEW YORK NY 10001
Aaron David Wasserman	officer: Chief Compliance Officer	50 HUDSON YARDS, NEW YORK NY 10001
Lorenzo Flores	director	2100 LOGIC DRIVE, SAN JOSE CA 95124
James Phillip Holloman	director	P.O. BOX 625737, 6800 CINTAS BOULEVARD, CINCINNATI OH 45262
Stayce D. Harris	director	1999 S. BASCOM AVE., SUITE 700, CAMPBELL CA 95008
Trent Walker	officer: Chief Financial Officer	C/O PIMCO, 650 NEWPORT CENTER DRIVE, NEWPORT BEACH CA 92660
Xiang Liu	other: Portfolio Manager	55 EAST 52ND STREET, NEW YORK NY 10055
Jeffrey Gene Lee	other: Portfolio Manager	55 EAST 52ND STREET, NEW YORK NY 10055
Blackrock Financial Management Inc/de	other: Affil. of Investment Adviser	100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Robert Glenn Hubbard	director	100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Robert W Fairbairn	director	55 EAST 52ND STREET, NEW YORK NY 10055